Released on = May 25, 2007, 3:23 am

Press Release Author = Shushmul Maheshwari

Industry = Biotech

Press Release Summary = Indian pharmaceutical sector is thriving with the boom in
bio pharma segment, which accounted for almost 70% of domestic sales in pharma
sector during 2005-06.

Press Release Body = In its recent study “Opportunities in Indian Pharma
Sector” RNCOS has found that, currently, India holds almost US$6 Billion of
the US$550 Billion pharmaceutical industry globally. The share of India is
increasing at 10% per year. In sharp contrast of the 7% annual growth observed by
the overall global markets, this figure speaks of a very promising scenario.

Assocham, the industry body, has revealed that Indian biotechnology sector should
grow more than thrice from US$1.5 Billion in 2004-05 to US$5 Billion by the year
2009-2010.

Indian biotech industry, based upon industry inputs, is all set to emerge as a hub
for clinical & biological services, and custom research. And within biotechnology,
bio-pharma is the segment that’s growing most swiftly. During 2005-06,
Bio-pharma was accountable for 70% of domestic sales in pharmaceuticals sector.

According to Assocham, there’re above 300 biotechnology firms in India that
focus on various facets of the value-chain, however, nearly 50% of the revenue is
concentrated with top ten players. In India, bio-generics and vaccines are the most
common interest areas for major firms such as Bharat Biotech, Dr Reddy’s Lab,
Workhardt, Zydus, etc. The country is already the 2nd largest maker of vaccines that
are used by kids and these vaccines are exported to more than 100 countries.

As per RNCOS’ market research report on “Opportunities in Indian Pharma
Sector”, “Bio-Pharma market is witnessing an unswerving growth trend,
with year 2004 observing record vaccine sales of US$386.3 Million. India is fast
emerging as the center for global vaccine market. It’s expected that Indian
pharmaceutical firms will supply 90% of the worldwide demand for measles-vaccine in
the years to come. Apart from vaccines, diagnostics is another rapidly growing
segment of Indian bio pharma sector. In 2004, diagnostic market recorded sales of
for US$ 138.2 Million.”

The report further provides extensive research and objective analysis of the Pharma
Sector in India. This report helps clients in analyzing the opportunities critical
to the growth of the Pharma Sector in India. Key facts and issues analyzed in this
report include: emerging trends in the Pharmaceutical sector in India, future
prospects of the Pharmaceutical Industry in India, key players in the Pharmaceutical
market in India, Opportunities and challenges in the Pharmaceutical market, and so
on.

About RNCOS E-Services Pvt Ltd.:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://www.rncos.com/Report/IM055.htm
Current Industry News: http://www.rncos.com/blog


Web Site = http://www.rncos.com

Contact Details = RNCOS E-Services Pvt Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com